Related Experiment Video
Updated: Jan 9, 2026
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
QingXia HuaYu Formula Alleviates Severe Acute Pancreatitis-Associated Intestinal Injury by Modulating Group 3 Innate
Yuyang Liu1,2, Yishuang Tang3, Yue Wu1
1Department of Gastroenterology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Background:
Severe acute pancreatitis (SAP), one of the common causes of acute abdomen in clinical practice, is characterized by acute and rapid onset as well as the systemic inflammatory response syndrome, which often leads to intestinal injury and high mortality. Recent studies indicate that innate lymphoid cells (ILCs) play an important role in the connection of SAP and intestinal injury. TCM, including the QingXia HuaYu (QXHY) formula, is known to benefit gastrointestinal dysfunction in SAP, but its mechanisms, especially regarding ILCs, are unclear.
Methods:
A mouse model of SAP was established by retrograde infusion of sodium taurocholate into the common bile duct of C57BL/6 mice. QXHY was orally administered three times postinfusion. Serum inflammatory markers, pancreatic myeloperoxidase, and histopathological changes in the mice with SAP with or without QXHY treatment were used to evaluate the pancreatic injury and the therapeutic effects of QXHY. Intestinal tight junctions, serum markers for mucosal injury, and inflammatory factors were used to analyze the effects of QXHY on intestinal injury in SAP mice. Flow cytometry and qRT-PCR were used to analyze ILC3s numbers and functions.
Results:
QXHY significantly reduced serum amylase, pancreatic myeloperoxidase, and improved histopathological manifestations in SAP mice. In addition, QXHY reduced intestinal damage, improved tight junction integrity, and lowered proinflammatory cytokines. Mechanistically, QXHY restored the diminished RORγt+-ILC3s in SAP mice and upregulated the expression of IL-22 (interleukin-22) and IL-17 (interleukin-17) mRNA.
Conclusion:
QXHY mitigates SAP-associated intestinal damage by enhancing ILC3 cells to regulate tissue injury and maintain homeostasis. Our data suggest that QXHY is a promising alternative and cost-friendly therapy for SAP-associated intestinal damage.
Related Concept Videos
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...